LIPAGLYN is a groundbreaking pharmaceutical product designed to address the complexities of metabolic disorders. With its active ingredient, Saroglitazar, this medication plays a pivotal role in the management of dyslipidemia, a condition characterized by abnormal lipid levels in the blood.